David C. Zawieja

David C. Zawieja

Auto-generated profile, based on publicly available information

David C. Zawieja

Department of Medical Physiology, Texas A&M Health Science Center, Temple, TX 76504

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in Lymphatic Research and Biology
Verified
Journal Article
Closed access
DZDavid C. Zawieja
David C. Zawieja
The lymphatic system has important roles in body fluid regulation, macromolecular homeostasis, lipid absorption, and immune function. To accomplish these roles, lymphatics must move fluid and its other contents (macromolecules, lipids/chylomicra, immune cells) from the interstitium through the lymphatics, across the nodes, and into the great veins. Thus, the principal task of the lymphatic vascular system is transport. The body must impart energy to the lymph via pumping mechanisms to propel it along the lymphatic network and use pumps and valves to generate lymph flow and prevent its backflow. The lymphatic system utilizes both extrinsic pumps, which rely on the cyclical compression and expansion of lymphatics by surrounding tissue forces, and intrinsic pumps, which rely on the intrinsic rapid/phasic contractions of lymphatic muscle. The intrinsic lymph pump function can be modulated by neural, humoral, and physical factors. Generally, increased lymph pressure/stretch of the muscular lymphatics activates the intrinsic lymph pump, while increased lymph flow/shear in the muscular lymphatics can either activate or inhibit the intrinsic lymph pump depending on the pattern and magnitude of the flow. To regulate lymph transport, lymphatic pumping and resistance must be controlled. A better understanding of these mechanisms could provide the basis for the development of better diagnostic and treatment modalities for lymphatic dysfunction.

1 January 2006 in Microcirculation
Verified
Journal Article
Closed access
PDF file
BDBrandon Dixon
Brandon Dixon
SGSteven T. Greiner
Steven T. Greiner
AGAnatoliy A. Gashev
Anatoliy A. Gashev
GCGerard L. Cote
Gerard L. Cote
JMJames E. Moore
James E. Moore
DZDavid C. Zawieja
David C. Zawieja
Objective: To measure lymphocyte velocity, lymphatic contraction, and shear stress in phasically contracting lymphatics in situ. Methods: A high‐speed video system was used to capture multiple contraction cycles in rat mesenteric lymphatic preparations. The images were analyzed to determine fluid velocity, volume flow rate, wall shear stress, and retrograde flow. Results: Lymphocyte density and flux varied from 326 to 35,500 cells/μ L and 206 to 2030 cells/min, respectively. Lymphatics contracted phasically, with a mean diameter 91 ± 9.0 μ m and amplitudes of 39%. Lymph velocity varied with the phasic contractions in both direction and magnitude with an average of 0.87 ± 0.18 and peaks of 2.2–9.0 mm/s. The velocity was ∼ 180° out of phase with the contraction cycle. The average lymph flow was 13.95 ± 5.27 μ L/h with transient periods of flow reversal. This resulted in an average shear of 0.64 ± 0.14 with peaks of 4–12 dynes/cm2. Conclusions: High‐speed lymphocyte tracking provided the spatial and temporal resolution to measure lymphocyte flux throughout the phasic contraction. Poiseuille flow was a reasonable model for estimating wall shear stress through most of the phasic contraction cycle of the intervalvular lymphatic segments. Shear rate was low but had large variations in magnitude compared to that seen in blood vessels.

9 July 2009 in Blood
Verified
Journal Article
Open access
PDF file
ASAmber N. Stratman
Amber N. Stratman
WSW. Brian Saunders
W. Brian Saunders
ASAnastasia Sacharidou
Anastasia Sacharidou
WKWonshill Koh
Wonshill Koh
KFKevin E. Fisher
Kevin E. Fisher
GDGeorge E Davis
George E Davis
Here we show that endothelial cells (EC) require matrix type 1-metalloproteinase (MT1-MMP) for the formation of lumens and tube networks in 3-dimensional (3D) collagen matrices. A fundamental consequence of EC lumen formation is the generation of vascular guidance tunnels within collagen matrices through an MT1-MMP-dependent proteolytic process. Vascular guidance tunnels represent a conduit for EC motility within these spaces (a newly remodeled 2D matrix surface) to both assemble and remodel tube structures. Interestingly, it appears that twice as many tunnel spaces are created than are occupied by tube networks after several days of culture. After tunnel formation, these spaces represent a 2D migratory surface within 3D collagen matrices allowing for EC migration in an MMP-independent fashion. Blockade of EC lumenogenesis using inhibitors that interfere with the process (eg, integrin, MMP, PKC, Src) completely abrogates the formation of vascular guidance tunnels. Thus, the MT1-MMP-dependent proteolytic process that creates tunnel spaces is directly and functionally coupled to the signaling mechanisms required for EC lumen and tube network formation. In summary, a fundamental and previously unrecognized purpose of EC tube morphogenesis is to create networks of matrix conduits that are necessary for EC migration and tube remodeling events critical to blood vessel assembly.

14 January 2010 in Blood
Verified
Journal Article
Open access
PDF file
MFMichael J. Flister
Michael J. Flister
AWAndrew Wilber
Andrew Wilber
KHKelly L. Hall
Kelly L. Hall
CICaname Iwata
Caname Iwata
KMKohei Miyazono
Kohei Miyazono
SRSophia Ran
Sophia Ran
The concept of inflammation-induced lymphangiogenesis (ie, formation of new lymphatic vessels) has long been recognized, but the molecular mechanisms remained largely unknown. The 2 primary mediators of lymphangiogenesis are vascular endothelial growth factor receptor-3 (VEGFR-3) and Prox1. The key factors that regulate inflammation-induced transcription are members of the nuclear factor-kappaB (NF-κB) family; however, the role of NF-κB in regulation of lymphatic-specific genes has not been defined. Here, we identified VEGFR-3 and Prox1 as downstream targets of the NF-κB pathway. In vivo time-course analysis of inflammation-induced lymphangiogenesis showed activation of NF-κB followed by sequential up-regulation of Prox1 and VEGFR-3 that preceded lymphangiogenesis by 4 and 2 days, respectively. Activation of NF-κB by inflammatory stimuli also elevated Prox1 and VEGFR-3 expression in cultured lymphatic endothelial cells, resulting in increased proliferation and migration. We also show that Prox1 synergizes with the p50 of NF-κB to control VEGFR-3 expression. Collectively, our findings suggest that induction of the NF-κB pathway by inflammatory stimuli activates Prox1, and both NF-κB and Prox1 activate the VEGFR-3 promoter leading to increased receptor expression in lymphatic endothelial cells. This, in turn, enhances the responsiveness of preexisting lymphatic endothelium to VEGFR-3 binding factors, VEGF-C and VEGF-D, ultimately resulting in robust lymphangiogenesis.

1 July 2011 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
MDMichael Davis
Michael Davis
ERElaheh Rahbar
Elaheh Rahbar
AGAnatoliy A. Gashev
Anatoliy A. Gashev
DZDavid C. Zawieja
David C. Zawieja
JJJames E. Moore Jr.
James E. Moore Jr.
Secondary lymphatic valves are essential for minimizing backflow of lymph and are presumed to gate passively according to the instantaneous trans-valve pressure gradient. We hypothesized that valve gating is also modulated by vessel distention, which could alter leaflet stiffness and coaptation. To test this hypothesis, we devised protocols to measure the small pressure gradients required to open or close lymphatic valves and determine if the gradients varied as a function of vessel diameter. Lymphatic vessels were isolated from rat mesentery, cannulated, and pressurized using a servo-control system. Detection of valve leaflet position simultaneously with diameter and intraluminal pressure changes in two-valve segments revealed the detailed temporal relationships between these parameters during the lymphatic contraction cycle. The timing of valve movements was similar to that of cardiac valves, but only when lymphatic vessel afterload was elevated. The pressure gradients required to open or close a valve were determined in one-valve segments during slow, ramp-wise pressure elevation, either from the input or output side of the valve. Tests were conducted over a wide range of baseline pressures (and thus diameters) in passive vessels as well as in vessels with two levels of imposed tone. Surprisingly, the pressure gradient required for valve closure varied >20-fold (0.1–2.2 cmH2O) as a passive vessel progressively distended. Similarly, the pressure gradient required for valve opening varied sixfold with vessel distention. Finally, our functional evidence supports the concept that lymphatic muscle tone exerts an indirect effect on valve gating.

1 July 2004 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
PWPierre-Yves von der Weid
Pierre-Yves von der Weid
DZDavid C. Zawieja
David C. Zawieja